Cancer Research Cancer Epigenetics Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nonet, G. H.
Right arrow Articles by Yaswen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nonet, G. H.
Right arrow Articles by Yaswen, P.
[Cancer Research 61, 1250-1254, February 15, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

The ZNF217 Gene Amplified in Breast Cancers Promotes Immortalization of Human Mammary Epithelial Cells1

Genevieve H. Nonet, Martha R. Stampfer, Koei Chin, Joe W. Gray, Colin C. Collins and Paul Yaswen2

Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720 [G. H. N., M. R. S., P. Y.], and University of California San Francisco Cancer Center, San Francisco, California 94143-0808 [K. C., J. W. G., C. C. C.]

Thefunctional consequences of overexpression of a candidate oncogene on chromosome 20q13.2, ZNF217, were examined by transducing the gene into finite life span human mammary epithelial cells (HMECs). In four independent experiments, ZNF217-transduced cultures gave rise to immortalized cells. HMECs that overcame senescence initially exhibited heterogeneous growth and continued telomere erosion, followed by increasing telomerase activity, stabilization of telomere length, and resistance to transforming growth factor ß growth inhibition. The incremental changes in telomerase activity and growth that occurred in ZNF217-transduced cultures after they overcame senescence were similar to the conversion pattern we have described previously in rare HMEC lines immortalized after exposure to a chemical carcinogen. Aberrant expression of ZNF217 may be selected for during breast cancer progression because it allows breast cells to overcome senescence and attain immortality.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
X. Zhao, L. Lu, N. Pokhriyal, H. Ma, L. Duan, S. Lin, N. Jafari, H. Band, and V. Band
Overexpression of RhoA Induces Preneoplastic Transformation of Primary Mammary Epithelial Cells
Cancer Res., January 15, 2009; 69(2): 483 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. Thillainadesan, M. Isovic, E. Loney, J. Andrews, M. Tini, and J. Torchia
Genome Analysis Identifies the p15ink4b Tumor Suppressor as a Direct Target of the ZNF217/CoREST Complex
Mol. Cell. Biol., October 1, 2008; 28(19): 6066 - 6077.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Zhao, M. Goswami, N. Pokhriyal, H. Ma, H. Du, J. Yao, T. A. Victor, K. Polyak, C. D. Sturgis, H. Band, et al.
Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression
Cancer Res., January 15, 2008; 68(2): 467 - 475.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. R. Krig, V. X. Jin, M. C. Bieda, H. O'Geen, P. Yaswen, R. Green, and P. J. Farnham
Identification of Genes Directly Regulated by the Oncogene ZNF217 Using Chromatin Immunoprecipitation (ChIP)-Chip Assays
J. Biol. Chem., March 30, 2007; 282(13): 9703 - 9712.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Q. Yang, K. L. Streicher, M. E. Ray, J. Abrams, and S. P. Ethier
Multiple Interacting Oncogenes on the 8p11-p12 Amplicon in Human Breast Cancer
Cancer Res., December 15, 2006; 66(24): 11632 - 11643.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K. G. R. Quinlan, M. Nardini, A. Verger, P. Francescato, P. Yaswen, D. Corda, M. Bolognesi, and M. Crossley
Specific Recognition of ZNF217 and Other Zinc Finger Proteins at a Surface Groove of C-Terminal Binding Proteins
Mol. Cell. Biol., November 1, 2006; 26(21): 8159 - 8172.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Ginestier, N. Cervera, P. Finetti, S. Esteyries, B. Esterni, J. Adelaide, L. Xerri, P. Viens, J. Jacquemier, E. Charafe-Jauffret, et al.
Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers
Clin. Cancer Res., August 1, 2006; 12(15): 4533 - 4544.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
S. Volik, B. J. Raphael, G. Huang, M. R. Stratton, G. Bignel, J. Murnane, J. H. Brebner, K. Bajsarowicz, P. L. Paris, Q. Tao, et al.
Decoding the fine-scale structure of a breast cancer genome and transcriptome
Genome Res., March 1, 2006; 16(3): 394 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
G. Huang, S. Krig, D. Kowbel, H. Xu, B. Hyun, S. Volik, B. Feuerstein, G. B. Mills, D. Stokoe, P. Yaswen, et al.
ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction
Hum. Mol. Genet., November 1, 2005; 14(21): 3219 - 3225.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. H. Yang, M. Y. Seo, H. J. Jeong, H.-C. Jeung, J. Shin, S. C. Kim, S. H. Noh, H. C. Chung, and S. Y. Rha
Gene Copy Number Change Events at Chromosome 20 and Their Association with Recurrence in Gastric Cancer Patients
Clin. Cancer Res., January 15, 2005; 11(2): 612 - 620.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Nakao, K. R. Mehta, J. Fridlyand, D. H. Moore, A. N. Jain, A. Lafuente, J. W. Wiencke, J. P. Terdiman, and F. M. Waldman
High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization
Carcinogenesis, August 1, 2004; 25(8): 1345 - 1357.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Holzmann, H. Kohlhammer, C. Schwaenen, S. Wessendorf, H. A. Kestler, A. Schwoerer, B. Rau, B. Radlwimmer, H. Dohner, P. Lichter, et al.
Genomic DNA-Chip Hybridization Reveals a Higher Incidence of Genomic Amplifications in Pancreatic Cancer than Conventional Comparative Genomic Hybridization and Leads to the Identification of Novel Candidate Genes
Cancer Res., July 1, 2004; 64(13): 4428 - 4433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Imoto, Y. Yuki, I. Sonoda, T. Ito, Y. Shimada, M. Imamura, and J. Inazawa
Identification of ZASC1 Encoding a Kruppel-like Zinc Finger Protein as a Novel Target for 3q26 Amplification in Esophageal Squamous Cell Carcinomas
Cancer Res., September 15, 2003; 63(18): 5691 - 5696.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Volik, S. Zhao, K. Chin, J. H. Brebner, D. R. Herndon, Q. Tao, D. Kowbel, G. Huang, A. Lapuk, W.-L. Kuo, et al.
End-sequence profiling: Sequence-based analysis of aberrant genomes
PNAS, June 24, 2003; 100(13): 7696 - 7701.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Bar-Shira, J. H. Pinthus, U. Rozovsky, M. Goldstein, W. R. Sellers, Y. Yaron, Z. Eshhar, and A. Orr-Urtreger
Multiple Genes in Human 20q13 Chromosomal Region Are Involved in an Advanced Prostate Cancer Xenograft
Cancer Res., December 1, 2002; 62(23): 6803 - 6807.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. P. Dimri, J.-L. Martinez, J. J. L. Jacobs, P. Keblusek, K. Itahana, M. van Lohuizen, J. Campisi, D. E. Wazer, and V. Band
The Bmi-1 Oncogene Induces Telomerase Activity and Immortalizes Human Mammary Epithelial Cells
Cancer Res., August 15, 2002; 62(16): 4736 - 4745.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. R. Stampfer, J. Garbe, G. Levine, S. Lichtsteiner, A. P. Vasserot, and P. Yaswen
Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells
PNAS, March 29, 2001; (2001) 71483998.
[Abstract] [Full Text]

Home page
 Genome ResHome page
C. Collins, S. Volik, D. Kowbel, D. Ginzinger, B. Ylstra, T. Cloutier, T. Hawkins, P. Predki, C. Martin, M. Wernick, et al.
Comprehensive Genome Sequence Analysis of a Breast Cancer Amplicon
Genome Res., June 1, 2001; 11(6): 1034 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. R. Stampfer, J. Garbe, G. Levine, S. Lichtsteiner, A. P. Vasserot, and P. Yaswen
Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells
PNAS, April 10, 2001; 98(8): 4498 - 4503.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.